| Self-perceived health by sex, age and labour status Eurostat | Eurostat | +35.3% |
| Self-perceived health by sex, age and educational attainment level Eurostat | Eurostat | 0 |
| Self-perceived health by sex, age and educational attainment level Eurostat | Eurostat | +3% |
| People having a long-standing illness or health problem, by sex, age and educational attainment level Eurostat | Eurostat | +4.8% |
| Level of disability (activity limitation) by sex, age and educational attainment level Eurostat | Eurostat | −1% |
| Level of disability (activity limitation) by sex, age and income quintile Eurostat | Eurostat | −30.2% |
| Self-reported unmet needs for medical examination by sex, age, main reason declared and educational attainment level Eurostat | Eurostat | 0 |
| Self-perceived health by sex, age and groups of country of birth Eurostat | Eurostat | −14.3% |
| Self-perceived health by sex, age and groups of country of citizenship Eurostat | Eurostat | +300% |
| Level of disability (activity limitation) by sex, age and country of birth Eurostat | Eurostat | +58.3% |
| Level of disability (activity limitation) by sex, age and country of birth Eurostat | Eurostat | +28.4% |
| Level of disability (activity limitation) by sex, age and citizenship Eurostat | Eurostat | +50% |
| Level of disability (activity limitation) by sex, age and citizenship Eurostat | Eurostat | +50% |
| Persons with financial burden of health care by level of difficulty, type of health care, household composition and risk of poverty threshold Eurostat | Eurostat | −11.8% |
| Persons visiting a doctor in the last 12 months by medical speciality, number of visits, educational attainment level, sex and age Eurostat | Eurostat | +13.2% |
| Persons performing physical activity outside working time by frequency in a typical week, educational attainment level, sex and age Eurostat | Eurostat | +25.7% |
| Persons performing physical activity outside working time by frequency in a typical week, body mass index and age Eurostat | Eurostat | – |
| Person distribution by body mass index, educational attainment level, sex and age Eurostat | Eurostat | +4.3% |
| Persons eating fruit, vegetables or salad by educational attainment level, risk of poverty threshold, most frequent activity status and sex Eurostat | Eurostat | −30.8% |
| Persons visiting a doctor in the last 12 months by sex, age, level of disability (activity limitation), medical specialty and number of visits Eurostat | Eurostat | +26.4% |
| Persons with financial burden of health care by sex, age, level of disability (activity limitation), type of health care and level of difficulty Eurostat | Eurostat | −5.7% |
| Obesity rate by body mass index (BMI) Eurostat | Eurostat | +1.3% |
| Share of people with good or very good perceived health by sex Eurostat | Eurostat | +1.8% |
| Self-reported unmet need for medical examination and care by sex Eurostat | Eurostat | −22.4% |
| Self-reported unmet needs for medical examination due to financial reasons, long waiting list or distance by sex, age and risk of poverty threshold - % of the persons having the same needs Eurostat | Eurostat | −11.1% |
| Self-reported unmet needs for medical examination due to financial reasons, long waiting list or distance by NUTS-2-region - % of the persons having the same needs Eurostat | Eurostat | −25% |
| Persons reporting needs for medical examination or treatment by sex, age and at risk of poverty and social exclusion situation Eurostat | Eurostat | +16.5% |
| Self-reported unmet needs for medical examination by main reason declared and NUTS 2 region Eurostat | Eurostat | 0 |
| Self-reported unmet needs for dental examination due to financial reasons, long waiting list or distance by sex, age and risk of poverty threshold - % of the persons having the same needs Eurostat | Eurostat | −56.8% |
| Persons reporting needs for dental examination or treatment by sex, age and at risk of poverty and social exclusion situation Eurostat | Eurostat | +20.8% |
| Health care expenditure by function Eurostat | Eurostat | +10.6% |
| Health care expenditure by function Eurostat | Eurostat | −0.2% |
| Health care expenditure by function Eurostat | Eurostat | +0.4% |
| Expenditure for selected health care functions by health care financing schemes Eurostat | Eurostat | −7.6% |
| Expenditure for selected health care functions by health care providers Eurostat | Eurostat | −7.1% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +13% |
| Health care expenditure by financing scheme Eurostat | Eurostat | +13.7% |
| Health care expenditure by financing scheme Eurostat | Eurostat | −1% |
| Health care expenditure by provider Eurostat | Eurostat | +8% |
| Expenditure for selected health care providers by health care financing schemes Eurostat | Eurostat | +8% |
| Revenues of health care financing schemes Eurostat | Eurostat | +10% |
| Revenues of health care financing schemes by health care financing schemes Eurostat | Eurostat | +13.4% |
| Crude suicide rates (per 100 000 population) WHO | WHO | – |
| Age-standardized suicide rates (per 100 000 population) WHO | WHO | +3.3% |
| Mortality rate attributed to unintentional poisoning (per 100 000 population) WHO | WHO | +300% |
| Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths WHO | WHO | +0.5% |
| Age-standardized NCD mortality rate (per 100 000 population) WHO | WHO | −4% |
| Total NCD Deaths WHO | WHO | −4.5% |
| Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease WHO | WHO | −2.3% |
| Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) WHO | WHO | −8.6% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | +0.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | −1.4% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | −0.7% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | +88.6% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | −47.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | −43.9% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | +117.6% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | +68.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | +81.7% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | +133.4% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | +91.3% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | +111.8% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, female (% of female population) Gender Statistics | Gender Statistics | +130.2% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, male (% of male population) Gender Statistics | Gender Statistics | +85% |
| Cause of death, by injury, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | +7.5% |
| Cause of death, by injury, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | +6.4% |
| Cause of death, by injury, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | +6.8% |
| Cause of death, by injury, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | −0.7% |
| Cause of death, by injury, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | −35.7% |
| Cause of death, by injury, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | −21.4% |
| Cause of death, by injury, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | −15.4% |
| Cause of death, by injury, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | −10.3% |
| Cause of death, by injury, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | −11.6% |
| Cause of death, by injury, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | −8.2% |
| Cause of death, by injury, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | −10.2% |
| Cause of death, by injury, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | −10.3% |
| Cause of death, by injury, female (% of female population) Gender Statistics | Gender Statistics | −11.4% |
| Cause of death, by injury, male (% of male population) Gender Statistics | Gender Statistics | −11.8% |
| Cause of death, by non-communicable diseases, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | −1.5% |
| Cause of death, by non-communicable diseases, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | −0.4% |
| Cause of death, by non-communicable diseases, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | −0.9% |
| Cause of death, by non-communicable diseases, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | −0.2% |
| Cause of death, by non-communicable diseases, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | +41% |
| Cause of death, by non-communicable diseases, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | +20.3% |
| Cause of death, by non-communicable diseases, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | −11.9% |
| Cause of death, by non-communicable diseases, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | −6.4% |
| Cause of death, by non-communicable diseases, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | −7.9% |
| Cause of death, by non-communicable diseases, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | −10.4% |
| Cause of death, by non-communicable diseases, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | −9.3% |
| Cause of death, by non-communicable diseases, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | −9.8% |
| Cause of death, by non-communicable diseases, female (% of female population) Gender Statistics | Gender Statistics | −10.4% |
| Cause of death, by non-communicable diseases, male (% of male population) Gender Statistics | Gender Statistics | −8.6% |
| Access to anti-retroviral drugs, female (%) Gender Statistics | Gender Statistics | +9.8% |
| Access to anti-retroviral drugs, male (%) Gender Statistics | Gender Statistics | +8.7% |
| Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49) Gender Statistics | Gender Statistics | 0% |
| Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49) Gender Statistics | Gender Statistics | 0% |
| Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24) Gender Statistics | Gender Statistics | 0% |
| Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24) Gender Statistics | Gender Statistics | 0% |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, female (per 100,000 female population) Gender Statistics | Gender Statistics | – |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, male (per 100,000 male population) Gender Statistics | Gender Statistics | – |
| Total alcohol consumption per capita, female (liters of pure alcohol, projected estimates, female 15+ years of age) World Development Indicators | World Development Indicators | +2% |
| Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age) World Development Indicators | World Development Indicators | +2.6% |
| Total alcohol consumption per capita, male (liters of pure alcohol, projected estimates, male 15+ years of age) World Development Indicators | World Development Indicators | +2.5% |
| Prevalence of anemia among women of reproductive age (% of women ages 15-49) World Development Indicators | World Development Indicators | +2.6% |
| Prevalence of anemia among children (% of children ages 6-59 months) World Development Indicators | World Development Indicators | +1.1% |
| Prevalence of anemia among non-pregnant women (% of women ages 15-49) World Development Indicators | World Development Indicators | +3% |
| Number of deaths ages 5-9 years World Development Indicators | World Development Indicators | −6.3% |
| Number of deaths ages 10-14 years World Development Indicators | World Development Indicators | 0% |
| Number of deaths ages 15-19 years World Development Indicators | World Development Indicators | −6.3% |
| Number of deaths ages 20-24 years World Development Indicators | World Development Indicators | −6.6% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total) World Development Indicators | World Development Indicators | +105.3% |
| Number of infant deaths World Development Indicators | World Development Indicators | 0% |
| Cause of death, by injury (% of total) World Development Indicators | World Development Indicators | −13.1% |
| Number of under-five deaths World Development Indicators | World Development Indicators | −1.3% |
| Cause of death, by non-communicable diseases (% of total) World Development Indicators | World Development Indicators | −9.4% |
| Number of neonatal deaths World Development Indicators | World Development Indicators | 0% |
| Probability of dying among children ages 5-9 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Probability of dying among adolescents ages 10-14 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Probability of dying among adolescents ages 15-19 years (per 1,000) World Development Indicators | World Development Indicators | −5.9% |
| Probability of dying among youth ages 20-24 years (per 1,000) World Development Indicators | World Development Indicators | −6.9% |
| Women's share of population ages 15+ living with HIV (%) World Development Indicators | World Development Indicators | +1% |
| Prevalence of HIV, total (% of population ages 15-49) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, under-5 (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, under-5, female (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, under-5, male (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) World Development Indicators | World Development Indicators | −4.1% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) World Development Indicators | World Development Indicators | −4.6% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%) World Development Indicators | World Development Indicators | −4.3% |
| Mortality rate, neonatal (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| People using safely managed drinking water services, urban (% of urban population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed drinking water services (% of population) World Development Indicators | World Development Indicators | 0% |
| Prevalence of HIV, female (% ages 15-24) World Development Indicators | World Development Indicators | 0% |
| Prevalence of HIV, male (% ages 15-24) World Development Indicators | World Development Indicators | 0% |
| Antiretroviral therapy coverage (% of people living with HIV) World Development Indicators | World Development Indicators | +8.3% |
| Incidence of HIV, all (per 1,000 uninfected population) World Development Indicators | World Development Indicators | 0% |
| Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24) World Development Indicators | World Development Indicators | 0% |
| Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49) World Development Indicators | World Development Indicators | 0% |
| Immunization, HepB3 (% of one-year-old children) World Development Indicators | World Development Indicators | −3.3% |
| Immunization, DPT (% of children ages 12-23 months) World Development Indicators | World Development Indicators | −1.1% |
| Immunization, measles (% of children ages 12-23 months) World Development Indicators | World Development Indicators | −1.1% |
| Hospital beds (per 1,000 people) World Development Indicators | World Development Indicators | −5.9% |
| Nurses and midwives (per 1,000 people) World Development Indicators | World Development Indicators | −4.5% |
| Physicians (per 1,000 people) World Development Indicators | World Development Indicators | −0.4% |
| Specialist surgical workforce (per 100,000 population) World Development Indicators | World Development Indicators | −5% |
| Number of maternal deaths World Development Indicators | World Development Indicators | 0% |
| Lifetime risk of maternal death (1 in: rate varies by country) World Development Indicators | World Development Indicators | +26% |
| Lifetime risk of maternal death (%) World Development Indicators | World Development Indicators | −20.6% |
| Prevalence of anemia among pregnant women (%) World Development Indicators | World Development Indicators | 0% |
| Prevalence of current tobacco use (% of adults) World Development Indicators | World Development Indicators | −0.9% |
| Prevalence of current tobacco use, females (% of female adults) World Development Indicators | World Development Indicators | −0.5% |
| Prevalence of current tobacco use, males (% of male adults) World Development Indicators | World Development Indicators | −0.7% |
| Number of surgical procedures (per 100,000 population) World Development Indicators | World Development Indicators | −57.8% |
| Mortality rate attributed to household and ambient air pollution, age-standardized, female (per 100,000 female population) World Development Indicators | World Development Indicators | – |
| Mortality rate attributed to household and ambient air pollution, age-standardized, male (per 100,000 male population) World Development Indicators | World Development Indicators | – |
| Mortality rate attributed to household and ambient air pollution, age-standardized (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Pregnant women receiving prenatal care (%) World Development Indicators | World Development Indicators | – |
| Births attended by skilled health staff (% of total) World Development Indicators | World Development Indicators | 0% |
| Low-birthweight babies (% of births) World Development Indicators | World Development Indicators | −4.3% |
| Diabetes prevalence (% of population ages 20 to 79) World Development Indicators | World Development Indicators | −3.8% |
| Prevalence of underweight, weight for age (% of children under 5) World Development Indicators | World Development Indicators | – |
| Maternal mortality ratio (modeled estimate, per 100,000 live births) World Development Indicators | World Development Indicators | −11.1% |
| Prevalence of overweight, weight for height, female (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +2.4% |
| Prevalence of overweight, weight for height, male (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +2.1% |
| Prevalence of overweight, weight for height (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +2.2% |
| Mortality rate attributed to unintentional poisoning (per 100,000 population) World Development Indicators | World Development Indicators | −41.2% |
| Mortality rate attributed to unintentional poisoning, female (per 100,000 female population) World Development Indicators | World Development Indicators | +78.4% |
| Mortality rate attributed to unintentional poisoning, male (per 100,000 male population) World Development Indicators | World Development Indicators | −54.6% |
| People using safely managed sanitation services, rural (% of rural population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services, urban (% of urban population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services (% of population) World Development Indicators | World Development Indicators | 0% |
| Prevalence of stunting, height for age, female (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +7.7% |
| Prevalence of stunting, height for age, male (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | 0% |
| Prevalence of stunting, height for age (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +6.7% |
| Suicide mortality rate, female (per 100,000 female population) World Development Indicators | World Development Indicators | −8.9% |
| Suicide mortality rate, male (per 100,000 male population) World Development Indicators | World Development Indicators | −10.3% |
| Suicide mortality rate (per 100,000 population) World Development Indicators | World Development Indicators | −9.8% |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Prevalence of wasting, weight for height (% of children under 5) World Development Indicators | World Development Indicators | – |
| Prevalence of severe wasting, weight for height (% of children under 5) World Development Indicators | World Development Indicators | – |
| Tuberculosis treatment success rate (% of new cases) World Development Indicators | World Development Indicators | −1.1% |
| Tuberculosis case detection rate (%, all forms) World Development Indicators | World Development Indicators | 0% |
| Incidence of tuberculosis (per 100,000 people) World Development Indicators | World Development Indicators | −8.8% |
| Current health expenditure (% of GDP) World Development Indicators | World Development Indicators | +3.8% |
| Current health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +9.2% |
| Current health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +8.1% |
| External health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | −49.9% |
| External health expenditure per capita (current US$) World Development Indicators | World Development Indicators | −44.1% |
| External health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | −48.2% |
| Domestic general government health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | −0.5% |
| Domestic general government health expenditure (% of GDP) World Development Indicators | World Development Indicators | +0.5% |
| Domestic general government health expenditure (% of general government expenditure) World Development Indicators | World Development Indicators | −2.5% |
| Domestic general government health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +11.1% |
| Domestic general government health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +2.9% |
| Out-of-pocket expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +1.3% |
| Out-of-pocket expenditure per capita (current US$) World Development Indicators | World Development Indicators | +10.6% |
| Out-of-pocket expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +9.5% |
| Domestic private health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +1.9% |
| Domestic private health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +13.7% |
| Domestic private health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +5.4% |
| Prevalence of undernourishment (% of population) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, adult, female (per 1,000 female adults) World Development Indicators | World Development Indicators | −1.3% |
| Mortality rate, adult, male (per 1,000 male adults) World Development Indicators | World Development Indicators | −1.6% |
| Contraceptive prevalence, any modern method (% of married women ages 15-49) World Development Indicators | World Development Indicators | −1.8% |
| Contraceptive prevalence, any method (% of married women ages 15-49) World Development Indicators | World Development Indicators | +5.3% |
| Mortality rate, infant, female (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, infant (per 1,000 live births) World Development Indicators | World Development Indicators | −3.4% |
| Mortality rate, infant, male (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| Life expectancy at birth, female (years) World Development Indicators | World Development Indicators | −0.4% |
| Life expectancy at birth, total (years) World Development Indicators | World Development Indicators | −0.1% |
| Life expectancy at birth, male (years) World Development Indicators | World Development Indicators | +0.1% |
| Survival to age 65, female (% of cohort) World Development Indicators | World Development Indicators | 0% |
| Survival to age 65, male (% of cohort) World Development Indicators | World Development Indicators | −0.1% |
| Population ages 75-79, female (% of female population) World Development Indicators | World Development Indicators | +5% |
| Population ages 75-79, male (% of male population) World Development Indicators | World Development Indicators | +5.9% |
| Population ages 80 and above, female (% of female population) World Development Indicators | World Development Indicators | −0.2% |
| Population ages 80 and above, male (% of male population) World Development Indicators | World Development Indicators | −0.4% |
| Completeness of birth registration (%) World Development Indicators | World Development Indicators | 0% |
| Completeness of death registration with cause-of-death information (%) World Development Indicators | World Development Indicators | −1% |
| Unmet need for contraception (% of married women ages 15-49) World Development Indicators | World Development Indicators | – |
| Number of female leprosy new cases WHO | WHO | 0 |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population WHO | WHO | 0 |
| Number of non-autochthonous leprosy cases WHO | WHO | 0 |
| New leprosy case detection rate per 1 000 000 population WHO | WHO | 0 |
| Leprosy - Number of cases registered for treatment WHO | WHO | 0 |
| Leprosy registered prevalence rate per 1 000 000 population WHO | WHO | 0 |
| Number of new G2D leprosy cases WHO | WHO | 0 |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population WHO | WHO | 0 |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases with G2D among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases WHO | WHO | 0 |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | +16% |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | – |
| Chronic hepatitis B (HBV) infected persons diagnosed (number) WHO | WHO | – |
| Chronic hepatitis C (HCV) infected persons diagnosed, including cured (number) WHO | WHO | – |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | +78.5% |
| Chronic hepatitis C (HCV) diagnosis coverage as percentage of total HCV infected, including cured (%) WHO | WHO | – |
| Life expectancy at birth (years) WHO | WHO | +2% |
| Healthy life expectancy (HALE) at birth (years) WHO | WHO | +1.8% |
| Healthy life expectancy (HALE) at age 60 (years) WHO | WHO | +6.1% |
| Life expectancy at age 60 (years) WHO | WHO | +6.8% |
| Causes of death - infant mortality by country of occurrence Eurostat | Eurostat | 0 |
| Peri-neonatal mortality by age of mother, by residence and occurrence Eurostat | Eurostat | 0% |
| Fetal, peri- and neonatal mortality rates by country of occurrence Eurostat | Eurostat | −20% |
| Deaths related to infectious diseases Eurostat | Eurostat | +1.3% |
| Deaths related to transport accidents occurring in the country Eurostat | Eurostat | −50% |
| Children by level of general health, household composition, quantile and age Eurostat | Eurostat | −81.8% |
| Children with limitation in activities due to health problems, by income group, household composition and age Eurostat | Eurostat | +8.7% |
| Children with limitation in activities due to health problems, by income group, household composition and age Eurostat | Eurostat | +55.2% |
| Children with unmet needs for medical examination or treatment by specific reason Eurostat | Eurostat | 0 |
| Deaths by age, sex and legal marital status Eurostat | Eurostat | −3.1% |
| Excess mortality by month Eurostat | Eurostat | +33.3% |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) WHO | WHO | −1% |
| Physical activity policies for activie societies WHO | WHO | 0% |
| Physical activity policies focused on active systems WHO | WHO | 0% |
| Number of imported cases of visceral leishmaniasis reported WHO | WHO | 0 |
| Proportion of cities, municipalities and localities in regional Healthy City networks that are health-promoting WHO | WHO | – |
| Overweight numbers among children under 5 years of age (thousands), model-based estimates WHO | WHO | −3.1% |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates WHO | WHO | +2.4% |
| Stunting numbers among children under 5 years of age (millions), model-based estimates WHO | WHO | 0% |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates WHO | WHO | 0% |
| Out-of-pocket expenditure on healthcare Eurostat | Eurostat | +2.3% |
| Total health care expenditure Eurostat | Eurostat | +10.8% |
| Long-term care (health) expenditure Eurostat | Eurostat | +14% |
| Number of under-five deaths WHO | WHO | −1.3% |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) WHO | WHO | 0% |
| Stillbirth rate (per 1000 total births) WHO | WHO | −3.8% |
| Number of deaths among children ages 5 to 9 years WHO | WHO | 0% |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) WHO | WHO | 0% |
| Number of neonatal deaths WHO | WHO | 0% |
| Neonatal mortality rate (per 1000 live births) WHO | WHO | 0% |
| Number of deaths among children 5 to 14 years of age WHO | WHO | −2.9% |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) WHO | WHO | −9.1% |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) WHO | WHO | +5.6% |
| Number of infant deaths WHO | WHO | 0% |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) WHO | WHO | −3.4% |
| Number of deaths among adolescents (10 to 19 years of age) WHO | WHO | 0% |
| Adolescent mortality rate (per 1 000 age specific cohort) WHO | WHO | 0% |
| Hepatitis B surface antigen (HBsAg) prevalence (%) WHO | WHO | −50% |
| Estimated number of people (all ages) living with HIV WHO | WHO | +2.7% |
| Reported number of people receiving antiretroviral therapy WHO | WHO | +6.5% |
| Reported number of children receiving antiretroviral therapy WHO | WHO | +7.1% |
| Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission WHO | WHO | +57.1% |
| Estimated antiretroviral therapy coverage among people living with HIV (%) WHO | WHO | +3.9% |
| Prevalence of HIV among adults aged 15 to 49 (%) WHO | WHO | 0% |
| New HIV infections (per 1000 uninfected population) WHO | WHO | 0% |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) WHO | WHO | – |
| Acute care OECD | OECD | −2.7% |
| Cancer care OECD | OECD | +2.4% |
| End-of-life care OECD | OECD | −15.9% |
| Healthcare quality and outcomes OECD | OECD | −15.9% |
| Integrated care OECD | OECD | −13.9 |
| Mental healthcare OECD | OECD | 0% |
| Primary care OECD | OECD | −3.9% |
| Prescribing in primary care OECD | OECD | – |
| Patient safety OECD | OECD | −17.6% |
| Self-reported unmet needs for medical examination by sex, age, main reason declared and income quintile Eurostat | Eurostat | 0 |
| Level of disability (activity limitation) by sex, age and degree of urbanisation Eurostat | Eurostat | +12.5% |
| Self-reported unmet need for medical care by sex Eurostat | Eurostat | −22.4% |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | −1.1% |
| Healthy life years by sex (from 2004 onwards) Eurostat | Eurostat | +6.9% |